AbSci Garners $5,100,000 Series A Funding Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=28b23009-7ef1-4f78-ab77-d5ce2e703299 - Date
4/26/2016 - Company Name
AbSci - Mailing Address
4640 SW Macadam Ave. Portland, OR 97239 USA - Company Description
AbSci is a global leader in cutting-edge protein production technologies committed to reducing costs in the biopharmaceutical industry. - Website
http://www.abscibio.com - Transaction Type
Venture Equity - Transaction Amount
$5,100,000 - Transaction Round
Series A - Proceeds Purposes
Funding will accelerate commercialization of AbSci’s SoluPro™ protein expression platform for use in biopharmaceutical manufacturing. - M&A Terms
- Venture Investor
Phoenix Venture Partners - Venture Investor
Undisclosed
